U.S. Health Insurers See Costs Mount, Income Estimates Decline In Q2

Most major US health insurers reported a challenging Q2, with operating income and EPS largely missing analyst estimates due to escalating medical costs, particularly in government-subsidized Medicare Advantage and Medicaid plans. Centene Corp. significantly underperformed, slashing its full-year EPS guidance by over 75% and attributing issues to underpriced business amid shifting morbidity trends, prompting aggressive 2026 price increase filings. UnitedHealth Group also saw a substantial operating income decline. In contrast, Humana Inc. outperformed peers, exceeding estimates and raising full-year projections, driven by growth in its Medicaid and pharmacy segments and stable Medicare Advantage trends, highlighting a divergent performance within a sector facing persistent elevated medical cost pressures.

Analysis

The U.S. managed care sector experienced significant pressure in the second quarter, with most major insurers reporting operating income and EPS figures below consensus estimates due to rising medical costs in government-subsidized health plans. A clear performance divergence has emerged among the top six publicly traded insurers. Humana (HUM) stands out as a notable outperformer, exceeding operating income consensus by 6.1% year-to-date and raising its full-year earnings guidance, attributing the success to growth in its Medicaid and pharmacy (CenterWell) businesses and a smaller-than-anticipated decline in Medicare Advantage membership. In stark contrast, Centene (CNC) reported a 93.2% miss on operating income consensus and drastically cut its full-year adjusted diluted EPS guidance from over $7.25 to $1.75, citing significantly higher market morbidity that rendered its business underpriced. Similarly, UnitedHealth Group (UNH) saw its operating income fall 43.2% below consensus amid ongoing cost pressures that also prompted a CEO change in May. Other players reflect the challenging environment with varying resilience; Elevance Health (ELV) lowered its EPS forecast to $30, warning of persistent cost trends, while The Cigna Group (CI) was the only insurer to maintain its guidance. Molina Healthcare (MOH) reduced its EPS forecast to $19 but framed it as a 'floor' with potential upside, supported by strong premium growth.

Key Decisions for Investors

• Investors should approach the managed care sector with a high degree of selectivity, as company-specific execution and exposure to government plan cost trends are creating significant winners and losers.
• Humana (HUM) warrants consideration for a long position, given its demonstrated ability to outperform peers, raise guidance in a challenging environment, and effectively manage its diversified business mix.
• Extreme caution is advised for Centene (CNC) due to its severe earnings miss and guidance slash; its recovery is contingent on the successful repricing of its 2026 portfolio, which remains an execution risk.
• Monitor UnitedHealth (UNH) for signs of stabilization following its management shake-up and persistent underperformance, as current headwinds show no signs of abating in the near term.
• Consider holding positions in The Cigna Group (CI) for its relative stability, while watching Molina Healthcare (MOH) to see if its optimistic 'earnings floor' and premium growth materialize into future upside.